Fondaparinux Sodium

• Status: MF No.: 230MF10028; USDMF to be filed in Q4,2020 • Patent Expiration: Off-patent • Usage:Anticoagulant

• Status: ASMF Approved & DMF No.:034091 • Patent Expiration:Off-patent • Usage:Antifungal

Brightgene Bio-Medical Technology Co.Ltd. Offers a wide range of anti-infective products which includes entecavir monohydrate. It belongs to anti-viral category. Contact us for more information. • Status: DMF No.:031949 • Patent Expiration: Off-patent • Usage:AntiHBV

• Status: Validated • Patent Expiration: US：2023.07.20 ；CN：off-patent • Usage: Oncology

• Status: DMF No.:032020 • Patent Expiration: Off-patent • Usage: Oncology

• Status: DMF No.: 028803 • Patent Expiration: US：2027.03.04; • Usage: Anti-infection

• Status:  • DMF No.:031449 • ASMF Approved • MF No.: 230MF10169 • Patent Expiration: Off-patent • Usage:Antifungal

• Status: DMF No.: 028314 • Patent Expiration: Off-patent • Usage: Antifungal

• Status: Pilot • Patent Expiration: US: 2027.1.1 • Usage: Anti-infection

• Status: Validated • Patent Expiration: ODE：2022.10.23；NCE：2020.10.23 • Usage: Oncology

• Status: Pre-validation • Patent Expiration: US：2022.11 • Usage: Intestinal Ostruction

• Status: DMF No.:032346 • Patent Expiration: Off-patent • Usage: Antifungal